Abstract
Ulcerative colitis (UC) represents a chronic inflammatory bowel disease associated with an increasing incidence worldwide. In Germany, the incidence is approximately 4:100,000; thus roughly 40,000 patients suffer from UC. The clinical picture can differ significantly, and a thorough knowledge of the treatment algorithms is of eminent importance since the prognosis and quality of life of the patients strongly depend on precise medical and surgical regimens.
Zusammenfassung
Die Colitis ulcerosa ist eine chronisch-entzündliche Darmerkrankung mit weltweit zunehmender Inzidenz. In Deutschland liegt die Inzidenz bei etwa 4:100.000; folglich leiden ungefähr 40.000 Patienten an der Erkrankung. Das klinische Bild der Colitis ulcerosa zeigt eine erhebliche Varianz. Eine gründliche Kenntnis der Behandlungsalgorithmen ist von großer Bedeutung, da Prognose und Lebensqualität der Patienten stark von präzisen medikamentösen und operativen Therapieregimen abhängig sind.
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs00053-020-00440-1/MediaObjects/53_2020_440_Fig1_HTML.jpg)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs00053-020-00440-1/MediaObjects/53_2020_440_Fig2_HTML.png)
Similar content being viewed by others
References
Molodecky NA, Soon IS, Rabi DM, Ghali WA, Ferris M, Chernoff G et al (2012) Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology 142(1):46–54.e42 (quiz e30)
Rungoe C, Langholz E, Andersson M, Basit S, Nielsen NM, Wohlfahrt J, Jess T (2014) Changes in medical treatment and surgery rates in inflammatory bowel disease: a nationwide cohort study 1979–2011. Gut 63(10):1607–1616
Bojic D, Radojicic Z, Nedeljkovic-Protic M, Al-Ali M, Jewell DP, Travis SP (2009) Long-term outcome after admission for acute severe ulcerative colitis in oxford: the 1992–1993 cohort. Inflamm Bowel Dis 15(6):823–828
Turner D, Walsh CM, Steinhart AH, Griffiths AM (2007) Response to corticosteroids in severe ulcerative colitis: a systematic review of the literature and a meta-regression. Clin Gastroenterol Hepatol 5(1):103–110
Truelove SC, Witts LJ (1955) Cortisone in ulcerative colitis; final report on a therapeutic trial. Br Med J 2(4947):1041–1048
Hanauer SB (1996) Inflammatory bowel disease. N Engl J Med 334(13):841–848
Hart AL, Ng SC (2010) Review article: the optimal medical management of acute severe ulcerative colitis. Aliment Pharmacol Ther 32(5):615–627
Kaplan GG, McCarthy EP, Ayanian JZ, Korzenik J, Hodin R, Sands BE (2008) Impact of hospital volume on postoperative morbidity and mortality following a colectomy for ulcerative colitis. Gastroenterology 134(3):680–687
Schmiegel W, Buchberger B, Follmann M, Graeven U, Heinemann V, Langer T et al (2017) S3-Leitlinie – kolorektales Karzinom. Z Gastroenterol 55(12):1344–1498
Hahnloser D, Pemberton JH, Wolff BG, Larson DR, Crownhart BS, Dozois RR (2007) Results at up to 20 years after ileal pouch-anal anastomosis for chronic ulcerative colitis. Br J Surg 94(3):333–340
Farouk R, Pemberton JH (1997) Surgical options in ulcerative colitis. Surg Clin North Am 77(1):85–94
Galandiuk S, Pemberton JH, Tsao J, Ilstrup DM, Wolff BG (1991) Delayed ileal pouch-anal anastomosis. Complications and functional results. Dis Colon Rectum 34(9):755–758
Michelassi F, Lee J, Rubin M, Fichera A, Kasza K, Karrison T, Hurst RD (2003) Long-term functional results after ileal pouch anal restorative proctocolectomy for ulcerative colitis: a prospective observational study. Ann Surg 238(3):433–441 (discussion 442–5)
Bitton A, Buie D, Enns R, Feagan BG, Jones JL, Marshall JK et al (2012) Treatment of hospitalized adult patients with severe ulcerative colitis: Toronto consensus statements. Am J Gastroenterol 107(2):179–194 (author reply 195)
Munie S, Hyman N, Osler T (2013) Fate of the rectal stump after subtotal colectomy for ulcerative colitis in the era of ileal pouch-anal anastomosis. JAMA Surg 148(5):408–411
Powar MP, Martin P, Croft AR, Walsh A, Petersen D, Stevenson AR et al (2013) Surgical outcomes in steroid refractory acute severe ulcerative colitis: the impact of rescue therapy. Colorectal Dis 15(3):374–379
Hicks CW, Hodin RA, Bordeianou L (2014) Semi-urgent surgery in hospitalized patients with severe ulcerative colitis does not increase overall j‑pouch complications. Am J Surg 207(2):281–287
Schiergens TS, Hoffmann V, Schobel TN, Englert GH, Kreis ME, Thasler WE et al (2017) Long-term quality of life of patients with permanent end ileostomy: results of a nationwide cross-sectional survey. Dis Colon Rectum 60(1):51–60
Fazio VW, Kiran RP, Remzi FH, Coffey JC, Heneghan HM, Kirat HT et al (2013) Ileal pouch anal anastomosis: analysis of outcome and quality of life in 3707 patients. Ann Surg 257(4):679–685
Bikhchandani J, Polites SF, Wagie AE, Habermann EB, Cima RR (2015) National trends of 3‑versus 2‑stage restorative proctocolectomy for chronic ulcerative colitis. Dis Colon Rectum 58(2):199–204
Hicks CW, Hodin RA, Bordeianou L (2013) Possible overuse of 3‑stage procedures for active ulcerative colitis. JAMA Surg 148(7):658–664
Swenson BR, Hollenbeak CS, Koltun WA (2003) Factors affecting cost and length of stay associated with the ileal pouch-anal anastomosis. Dis Colon Rectum 46(6):754–761
McLeod RS (2003) Surgery for inflammatory bowel diseases. Dig Dis 21(2):168–179
Marcello PW, Milsom JW, Wong SK, Hammerhofer KA, Goormastic M, Church JM, Fazio VW (2000) Laparoscopic restorative proctocolectomy: case-matched comparative study with open restorative proctocolectomy. Dis Colon Rectum 43(5):604–608
Polle SW, Dunker MS, Slors JF, Sprangers MA, Cuesta MA, Gouma DJ, Bemelman WA (2007) Body image, cosmesis, quality of life, and functional outcome of hand-assisted laparoscopic versus open restorative proctocolectomy: long-term results of a randomized trial. Surg Endosc 21(8):1301–1307
Lacy AM, Saavedra-Perez D, Bravo R, Adelsdorfer C, Aceituno M, Balust J (2012) Minilaparoscopy-assisted natural orifice total colectomy: technical report of a minilaparoscopy-assisted transrectal resection. Surg Endosc 26(7):2080–2085
Zoccali M, Fichera A (2012) Minimally invasive approaches for the treatment of inflammatory bowel disease. World J Gastroenterol 18(46):6756–6763
Miller AT, Berian JR, Rubin M, Hurst RD, Fichera A, Umanskiy K (2012) robotic-assisted proctectomy for inflammatory bowel disease: a case-matched comparison of laparoscopic and robotic technique. J Gastrointest Surg 16(3):587–594
McGuire BB, Brannigan AE, O’Connell PR (2007) Ileal pouch-anal anastomosis. Br J Surg 94(7):812–823
Kühn F, Klar E (2015) Surgical principles in the treatment of ulcerative colitis. Viszeralmedizin 31(4):246–250
Kienle P, Z’graggen K, Schmidt J, Benner A, Weitz J, Büchler MW (2005) Laparoscopic restorative proctocolectomy. Br J Surg 92(1):88–93
Melton GB, Fazio VW, Kiran RP, He J, Lavery IC, Shen B et al (2008) Long-term outcomes with ileal pouch-anal anastomosis and crohn’s disease: pouch retention and implications of delayed diagnosis. Ann Surg 248(4):608–616
Hartley JE, Fazio VW, Remzi FH, Lavery IC, Church JM, Strong SA et al (2004) Analysis of the outcome of ileal pouch-anal anastomosis in patients with crohn’s disease. Dis Colon Rectum 47(11):1808–1815
Hata K, Ishihara S, Nozawa H, Kawai K, Kiyomatsu T, Tanaka T et al (2017) Pouchitis after ileal pouch-anal anastomosis in ulcerative colitis: diagnosis, management, risk factors, and incidence. Dig Endosc 29(1):26–34
Aberra FN, Lewis JD, Hass D, Rombeau JL, Osborne B, Lichtenstein GR (2003) Corticosteroids and immunomodulators: postoperative infectious complication risk in inflammatory bowel disease patients. Gastroenterology 125(2):320–327
Mahadevan U (2004) Medical treatment of ulcerative colitis. Clin Colon Rectal Surg 17(1):7–19
Subramanian V, Saxena S, Kang JY, Pollok RC (2008) Preoperative steroid use and risk of postoperative complications in patients with inflammatory bowel disease undergoing abdominal surgery. Am J Gastroenterol 103(9):2373–2381
Narula N, Charleton D, Marshall JK (2013) Meta-analysis: peri-operative anti-tnfα treatment and post-operative complications in patients with inflammatory bowel disease. Aliment Pharmacol Ther 37(11):1057–1064
Law CCY, Narula A, Lightner AL, McKenna NP, Colombel JF, Narula N (2018) Systematic review and meta-analysis: preoperative vedolizumab treatment and postoperative complications in patients with inflammatory bowel disease. J Crohns Colitis 12(5):538–545
Jess T, Rungoe C, Peyrin-Biroulet L (2012) Risk of colorectal cancer in patients with ulcerative colitis: a meta-analysis of population-based cohort studies. Clin Gastroenterol Hepatol 10(6):639–645
Eaden JA, Abrams KR, Mayberry JF (2001) The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut 48(4):526–535
Jess T, Frisch M (2013) Reply: risk of colorectal cancer. Gastroenterology 144(3):e22–3
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
M. Rentsch, C. McSharry, F. Kühn, A. Sint, P. Ganschow, J. Werner, and T. Schiergens declare that they have no competing interests.
For this article no studies with human participants or animals were performed by any of the authors. All studies performed were in accordance with the ethical standards indicated in each case.
Rights and permissions
About this article
Cite this article
Rentsch, M., McSharry, C., Kühn, F. et al. Indication for surgical therapy in ulcerative colitis. coloproctology 42, 339–344 (2020). https://doi.org/10.1007/s00053-020-00440-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00053-020-00440-1
Keywords
- Ulcerative colitis
- Severity-dependent treatment
- Surgical strategy
- Inflammatory bowel disease
- Severity score